AG Bayer
Bayer Has a Big Headache Bayer Suspends Two Employees over Trasylol Data Bayer insists that Trasylol heart drug is safe Bayer AG can expect a slowdown in the growth in sales of its blood loss drug Trasylol, after an independent study showed that the drug was associated with health risks, board member Wolfgang Plischke said after the full-year results news conference
Home | Site Map | Disclaimer